Bruce J. Dezube
Xilio Therapeutics (United States)(US)
Publications by Year
Research Areas
Viral-associated cancers and disorders, Lymphoma Diagnosis and Treatment, Ubiquitin and proteasome pathways, HIV Research and Treatment, HIV/AIDS drug development and treatment
Most-Cited Works
- → Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer(2010)4,491 cited
- → Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.(1998)640 cited
- → Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma(2019)545 cited
- → Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1(2005)491 cited
- → Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma(2014)477 cited
- → Open-label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast Cancer(2019)417 cited